Literature DB >> 12726995

The role of N-linked glycosylation in determining the surface expression, G protein interaction and effector coupling of the alpha (alpha) isoform of the human thromboxane A(2) receptor.

Leanne P Kelley1, B Therese Kinsella.   

Abstract

In humans, thromboxane (TX) A(2) signals through two TXA(2) receptor (TP) isoforms, termed TPalpha and TPbeta, that diverge exclusively within the carboxyl terminal cytoplasmic domains. The amino terminal extracellular region of the TPs contains two highly conserved Asn (N)-linked glycosylation sites at Asn(4) and Asn(16). While it has been established that impairment of N-glycosylation of TPalpha significantly affects ligand binding/intracellular signalling, previous studies did not ascertain whether N-linked glycosylation was critical for ligand binding per se or whether it was required for the intracellular trafficking and the functional expression of TPalpha on the plasma membrane (PM). In the current study, we investigated the role of N-linked glycosylation in determining the functional expression of TPalpha, by assessment of its ligand binding, G protein coupling and intracellular signalling properties, correlating it with the level of antigenic TPalpha protein expressed on the PM and/or retained intracellularly. From our data, we conclude that N-glycosylation of either Asn(4) or Asn(16) is required and sufficient for expression of functionally active TPalpha on the PM while the fully non-glycosylated TPalpha(N4,N16-Q4,Q16) is almost completely retained within the endoplasmic reticulum (ER) and remains functionally inactive, failing to associate with its coupling G protein Galpha(q) and, in turn, failing to mediate phospholipase (PL) Cbeta activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726995     DOI: 10.1016/s0304-4165(03)00059-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Thromboxane A2 receptor and MaxiK-channel intimate interaction supports channel trans-inhibition independent of G-protein activation.

Authors:  Min Li; Yoshio Tanaka; Abderrahmane Alioua; Yong Wu; Rong Lu; Pallob Kundu; Enrique Sanchez-Pastor; Jure Marijic; Enrico Stefani; Ligia Toro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-19       Impact factor: 11.205

Review 2.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

3.  Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.

Authors:  Alexander J Frey; Salam Ibrahim; Scott Gleim; John Hwa; Emer M Smyth
Journal:  J Lipid Res       Date:  2013-03-14       Impact factor: 5.922

4.  The role of N53Q mutation on the rat mu-opioid receptor function.

Authors:  A Rostami; M Rabbani; M Mir-Mohammad-Sadeghi
Journal:  J Biomol Tech       Date:  2010-07

Review 5.  Effects of Post-translational Modifications on Membrane Localization and Signaling of Prostanoid GPCR-G Protein Complexes and the Role of Hypoxia.

Authors:  Anurag S Sikarwar; Anjali Y Bhagirath; Shyamala Dakshinamurti
Journal:  J Membr Biol       Date:  2019-09-04       Impact factor: 1.843

6.  Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.

Authors:  Ana Paula Abreu; Sekoni D Noel; Shuyun Xu; Rona S Carroll; Ana Claudia Latronico; Ursula B Kaiser
Journal:  Mol Endocrinol       Date:  2012-06-28

7.  A simple, quick, and high-yield preparation of the human thromboxane A2 receptor in full size for structural studies.

Authors:  Ke-He Ruan; Vanessa Cervantes; Jiaxin Wu
Journal:  Biochemistry       Date:  2008-06-05       Impact factor: 3.162

8.  Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.

Authors:  Stephen J Wilson; Claire C Cavanagh; Allison M Lesher; Alexander J Frey; Shane E Russell; Emer M Smyth
Journal:  J Lipid Res       Date:  2009-01-16       Impact factor: 5.922

9.  High-level expression, purification and characterization of a constitutively active thromboxane A2 receptor polymorphic variant.

Authors:  Bing Xu; Raja Chakraborty; Markus Eilers; Shyamala Dakshinamurti; Joe D O'Neil; Steven O Smith; Rajinder P Bhullar; Prashen Chelikani
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.